ES8707731A1 - Un procedimiento para la preparacion de derivados de oxindol - Google Patents

Un procedimiento para la preparacion de derivados de oxindol

Info

Publication number
ES8707731A1
ES8707731A1 ES554609A ES554609A ES8707731A1 ES 8707731 A1 ES8707731 A1 ES 8707731A1 ES 554609 A ES554609 A ES 554609A ES 554609 A ES554609 A ES 554609A ES 8707731 A1 ES8707731 A1 ES 8707731A1
Authority
ES
Spain
Prior art keywords
oxindole
antiinflammatory agents
substituted
aminolysis
carboxamides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES554609A
Other languages
English (en)
Other versions
ES554609A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/666,953 external-priority patent/US4644005A/en
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of ES8707731A1 publication Critical patent/ES8707731A1/es
Publication of ES554609A0 publication Critical patent/ES554609A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • C07D491/044—Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/58—[b]- or [c]-condensed
    • C07D209/70—[b]- or [c]-condensed containing carbocyclic rings other than six-membered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

METODO DE PREPARAR DERIVADOS DE OXINDOL. CONSISTE EN HACER REACCIONAR UN COMPUESTO DE FORMULA HET-CO2R DONDE R ES ALQUILO DE C 1 A 3, CON UN COMPUESTO DE FORMULA AR-NH2, EN UN DISOLVENTE AROMATICO, A LA TEMPERATURA DE REFLUJO DEL DISOLVENTE, HASTA QUE LA REACCION SEA PRACTICAMENTE COMPLETA, PARA OBTENER DERIVADOS DE OXINDOL DE FORMULA HET-CONH-AR, DONDE HET ES UN GRUPO DE FORMULAS (I), (II) O (III)), DONDE Z ES 0 O METILENO; R1 ES FENILO O ALQUILO DE C 1 A 3; R4 ES UN SUSTITUYENTE EN LAS POSICIONES 5, 6 O 7 SELECCIONADO ENTRE ALCANOILO DE C 2 A 6, CICLOALCANOILO DE C 4 A 6 Y OTROS; Y AR ES FENILO, FLUORFENILO Y OTROS. TIENEN APLICACIONES FARMACEUTICAS COMO ANTIINFLAMATORIOS.
ES554609A 1984-10-31 1986-04-30 Un procedimiento para la preparacion de derivados de oxindol Expired ES8707731A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/666,953 US4644005A (en) 1984-10-31 1984-10-31 Oxindole antiinflammatory agents
US06/762,998 US4686224A (en) 1984-10-31 1985-08-06 Oxindole antiinflammatory agents

Publications (2)

Publication Number Publication Date
ES8707731A1 true ES8707731A1 (es) 1987-08-16
ES554609A0 ES554609A0 (es) 1987-08-16

Family

ID=27099577

Family Applications (1)

Application Number Title Priority Date Filing Date
ES554609A Expired ES8707731A1 (es) 1984-10-31 1986-04-30 Un procedimiento para la preparacion de derivados de oxindol

Country Status (16)

Country Link
US (1) US4686224A (es)
EP (1) EP0181136B1 (es)
KR (1) KR870001269B1 (es)
AU (1) AU555051B2 (es)
CA (1) CA1247099A (es)
DE (1) DE3585719D1 (es)
DK (1) DK163990C (es)
ES (1) ES8707731A1 (es)
FI (1) FI81340C (es)
GR (1) GR852629B (es)
HU (1) HU194168B (es)
IE (1) IE58207B1 (es)
IL (1) IL76854A (es)
PH (3) PH20985A (es)
PL (2) PL145239B1 (es)
PT (1) PT81393B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU215112B (hu) * 1989-01-10 1998-12-28 Pfizer Inc. Eljárás gyulladáscsökkentő 1-heteroaril-3-acil-2-oxindol-származékok előállítására
WO1990008146A1 (en) * 1989-01-10 1990-07-26 Pfizer Inc. Anti-inflammatory 1-heteroaryl-oxindole-3-carboxamides
JPH0717589B2 (ja) * 1990-01-22 1995-03-01 ファイザー製薬株式会社 新規１，３―ジカルボニル化合物およびその組成物
CH687764A5 (de) * 1992-07-02 1997-02-14 Lonza Ag Gampel Wallis Geschof Verfahren zur Herstellung von 7-Acylindolen.
US5449788A (en) * 1994-01-28 1995-09-12 Catalytica, Inc. Process for preparing 2-oxindole-1-carboxamides
GB9414139D0 (en) * 1994-07-13 1994-08-31 Smithkline Beecham Plc Novel compounds
KR100842791B1 (ko) 2000-09-14 2008-07-01 미쓰비시 타나베 파마 코퍼레이션 신규한 아미드 유도체 및 그의 의약적 용도
JP2004529110A (ja) 2001-03-06 2004-09-24 アストラゼネカ アクチボラグ 脈管損傷活性を有するインドール誘導体
EP2147679B1 (en) 2001-07-25 2014-06-25 Raptor Pharmaceutical, Inc. Compositions for blood-brain barrier transport
WO2005041957A1 (en) * 2003-10-29 2005-05-12 Pfizer Products Inc. Oxindole derivatives and their use as phosphodiesterase type 2 inhibitors
DK1889198T3 (da) 2005-04-28 2015-02-09 Proteus Digital Health Inc Farma-informatiksystem
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
DK2398500T3 (da) 2009-02-20 2019-05-13 2 Bbb Medicines B V Glutathion-baseret lægemiddelafgivelsessystem
IL255113B (en) 2009-05-06 2022-09-01 Laboratory Skin Care Inc Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates
CN104130176A (zh) * 2014-06-13 2014-11-05 天津科技大学 一种1,5-二取代吲哚酮类衍生物及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE756447A (fr) * 1969-10-15 1971-03-22 Pfizer Oxindolecarboxamides
US3749731A (en) * 1971-07-08 1973-07-31 Warner Lambert Co 2-oxo-n-(2-thiazolyl)-3-indoline-carboxamide
DE3114351A1 (de) * 1981-04-09 1982-11-04 Hoechst Ag, 6000 Frankfurt "oxindol-derivate, verfahren zu ihrer herstellung und sie enthaltende arzneimittel mit neuroanaboler wirkung"
AU8509882A (en) * 1981-06-30 1983-01-06 Merck & Co., Inc. Tricyclic derivatives of substituted pyrrole acids
GR850310B (es) * 1984-02-07 1985-06-05 Pfizer
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
GR850669B (es) * 1984-03-19 1985-07-25 Pfizer

Also Published As

Publication number Publication date
IL76854A (en) 1989-05-15
IE58207B1 (en) 1993-07-28
DK497685D0 (da) 1985-10-30
HUT39428A (en) 1986-09-29
KR860003260A (ko) 1986-05-21
FI81340C (fi) 1990-10-10
CA1247099A (en) 1988-12-20
FI854258A0 (fi) 1985-10-30
IE852703L (en) 1986-04-30
EP0181136A2 (en) 1986-05-14
DK163990B (da) 1992-04-27
KR870001269B1 (ko) 1987-06-30
AU4918985A (en) 1986-05-08
FI81340B (fi) 1990-06-29
HU194168B (en) 1988-01-28
PL145239B1 (en) 1988-08-31
EP0181136B1 (en) 1992-03-25
PT81393B (pt) 1988-02-17
PH23130A (en) 1989-05-05
EP0181136A3 (en) 1987-10-28
PH24091A (en) 1990-03-05
GR852629B (es) 1986-03-04
DK163990C (da) 1992-09-21
ES554609A0 (es) 1987-08-16
PT81393A (en) 1985-11-01
DK497685A (da) 1986-05-01
US4686224A (en) 1987-08-11
IL76854A0 (en) 1986-02-28
DE3585719D1 (de) 1992-04-30
PL150842B1 (en) 1990-07-31
FI854258L (fi) 1986-05-01
PH20985A (en) 1987-06-18
AU555051B2 (en) 1986-09-11
PL262327A1 (en) 1987-11-02
PL255990A1 (en) 1987-03-23

Similar Documents

Publication Publication Date Title
ES8707731A1 (es) Un procedimiento para la preparacion de derivados de oxindol
ES8203375A1 (es) Procedimiento de preparar triazoloquinoxalin-4-onas substi- tuidas antihipertensoras
ES8701737A1 (es) Un procedimiento para la preparacion de nuevas quinazolindionas.
AU8181782A (en) Electrolyzer for the production of hydrogen
EP0080378B1 (en) L-tryptophan-producing microorganisms
AU3588584A (en) Thiolane-2,4-dione-3-carboxamides
ES8308870A1 (es) Procedimiento para la preparacion de derivados de acido 5-(4-fenil-1-piperidinil) metil-2,3-dihidro-2-oxo-1h-imidazol-4-carboxilico.
AU2700988A (en) N-hydroxy-5-phenyl-2-furancarboximidamides useful as cardiotonic agents
SU1269296A1 (ru) Гербицидный состав
SU778314A1 (ru) Литейный сплав на основе алюминия
AU553641B2 (en) Regulated d.c. power supply
SU1133890A1 (ru) Литейный сплав на основе алюминия
SU928823A1 (ru) Сплав на основе алюминия
SU1251528A1 (ru) Пленка - подложка для культивирования животных клеток
SU1051923A1 (ru) Состав для покрытий
AU6972481A (en) 6-pyridyl-pyridazinones useful as cardiotonic agents
SU1271275A1 (ru) Матричный автоэлектронный катод
SU1269688A1 (ru) Источник ионов
SU1253113A1 (ru) Способ получения цис-1,4-полибутадиена
SU1244928A1 (ru) Способ получения цис-1,4-полибутадиена
SU1208765A1 (ru) Способ получения производных феноксифенилмочевины
ES8308857A1 (es) Procedimiento para preparar 4-oximetil-5-acil-1,3-dihidro-2h-imidazol-2-onas.
SU999919A1 (ru) Газовый лазер на парах химических элементов
SU1264575A1 (ru) Способ иммобилизации клеток
SU1172285A1 (ru) Сплав на основе алюминия

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 20020401